Pathologist interested in Urologic and Molecular Pathology | Postdoc Research Fellow @BrighamWomens and @HarvardMed
Boston, MA
Joined November 2021
- Tweets144
- Following663
- Followers208
- Likes557
Gabriel Roberti, MD retweeted
EV/P delivers again!!
Congrats to @MattGalsky , investigators and patients on EV/P showing prolonged EFS and OS compared to neoadjuvant gem/cis
A pivotal moment indeed #GU26
@OncoAlert
Gabriel Roberti, MD retweeted
Kidney day at #GU26 with many exciting posters from friends and colleagues:
Gabriel Roberti, MD retweeted
How to ever do sequencing studies with so many options coming down the pike? @Uromigos
Gabriel Roberti, MD retweeted
My table on histologic subtypes of urinary tract tumors during #simposioSOGUG25 @sogug1
🔸 UC with mixed HS has different biological behaviors.
🔸 Mixed variants are managed (so far) as conventional UC with the exception of small cell. #bladdercancer
Gabriel Roberti, MD retweeted
Eosinophilic Vacuolated Tumor (EVT) - generally considered benign/indolent & associated with MTOR pathway mutations. However, rarely it can be seen w/metastatic dz, as seen here (LVI+, LN+). 🔬@GU_Path_Society @IntSocUropath @AdanmaAnjiMD @Kiril_T_Can
doi.org/10.1111/his.70037
ALT EVT, KIT+, LVI+, LN+
Gabriel Roberti, MD retweeted
Some prostate cancers evade therapy by transforming into aggressive neuroendocrine prostate cancer. New research highlights PROX1 as a key driver of this transformation and tumor growth, offering a potential treatment target.
➡️ bit.ly/4lEFHoD
@CR_AACR @bajji @mishabeltran
Gabriel Roberti, MD retweeted
Insightful discussions, cutting edge research, great speakers, multidisciplinary approach & an amazing audience- perfect #kidneycancer meeting @kidneycan #KCRS2025 #genomics #pathology #cancer
Gabriel Roberti, MD retweeted
Molecular and Therapeutic Landscape of Non-Clear Cell Renal Cell Carcinoma:
🧬🧬🧬Diverse subtypes, unique genetics, unpredictable responses.
@NatRevUrol @OncoAlert @kidneycan @IKCCorg @KidneyCancer @MehrazinMD
rdcu.be/ewjT8
Gabriel Roberti, MD retweeted
Enjoy Kidney Cancer's Special Pathology Edition. A great set of [open access] RCC reviews; also, sarcomas, benign tumors, molecular changes, familial syndromes, grading/staging. Great for patients, clinicians, researchers & pathologists.🔬#gupath @urotoday
journals.sagepub.com/toc/kca…
Gabriel Roberti, MD retweeted
This helpful infographic from @genome_gov explains the challenges of sequencing highly repetitive DNA and the technological advances that were needed to generate the first truly complete (gapless) human genome sequence. I encourage you to check it out! genome.gov/about-genomics/ed…
Gabriel Roberti, MD retweeted
Assessment and classification of sex cord‐stromal tumours of the testis: recommendations from the testicular sex cord‐stromal tumour (TESST) group, an Expert Panel of GUPS and ISUP- Acosta - Histopathology - Wiley Online Library #openaccess onlinelibrary.wiley.com/doi/…
Gabriel Roberti, MD retweeted
🧾 Cheat Sheet on Follow-up for NMIBC
🔹 Risk-based surveillance
🔹 Lifelong follow-up for high-risk patients
🔹 Role of cytology & markers
🔍 No substitute for cystoscopy
Download Cheat Sheet:
uroweb.org/guidelines/non-mu…
#BladderCancer #NMIBC #EAUguidelines
Gabriel Roberti, MD retweeted
Big news!
Massachusetts General Hospital and Brigham and Women’s Hospital have been ranked #1 and #2 globally for research impact among healthcare institutions by the 2024 @NatureIndex.
Proud to be part of a pathology department at the forefront of discovery! 🧪🔬
#PathTwitter
Gabriel Roberti, MD retweeted
𝐂𝐑𝐈𝐒𝐏𝐑-𝐂𝐚𝐬𝟗 is a process in which clustered regularly interspaced short palindromic repeats (CRISPR) — small remnants of viral DNA from previous viral infection that are embedded in bacterial DNA — generate guide RNAs, which are used together with a DNA-cutting enzyme (Cas9) by the bacterium to defend against viral infection. With synthetic guide strands and an exogenous Cas enzyme, this technology can be used in eukaryotic cells to modify DNA or RNA for the purpose of gene editing.
To learn more about this NEJM Illustrated Glossary term, read the editorial “Personalized Gene Editing to Treat an Inborn Error of Metabolism” by @AndreaGropman, MD, and Alexis C. Komor, PhD (@KomorLab), from @StJude and @ucsandiego: nej.md/430hLWR
Explore more terms: nej.md/glossary
ALT Visual representation of "CRISPR-Cas9"